Abstract
Purpose. The aim of this work was to synthesize ionized dehydroepiandrosterone (DHEA) prodrugs with higher water solubility, useful for iontophoretic transdermal application.
Methods. The synthesized derivatives were characterized and tested for sensitivity to chemical and enzymatic hydrolysis. Solid state and solution stability was also determined. Transdermal iontophoretic anodal transport in vitro was studied using excised rabbit skin.
Results. Two DHEA ionized prodrugs were synthesized: PRO1, a primary amine derivative, and PRO2, a quaternary ammonium salt. The two derivatives possess higher water solubility and lower octanol/saline partition coefficients than DHEA. Prodrugs were sensitive to enzymatic hydrolysis; in particular the primary amine was hydrolyzed faster than the quaternary salt by esterase from porcine liver in vitro. Transdermal flux of the two prodrugs was slightly higher than the parent drug. In the case of passive diffusion, only DHEA was found in the receptor compartment, indicating the complete breakdown of the prodrug in the skin. Current application gave higher drug flux and a significant amount of prodrug was found in the receptor.
Conclusions. The use of ionized prodrugs of DHEA can increase the flux attainable during transdermal anodal iontophoresis by up to 7 times, but they are useful for passive transport as well.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
R. R. Watson, A. Huls, M. Araghinikuam, and S. Chung. Dehydroepiandrosterone and diseases of aging. Drugs-Aging 9:274-291 (1996).
A. J. Morales, J. J. Nolan, J. C. Nelson, and S. S. Yen. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78:1360-7 (1994).
J. E. Buster, P. R. Casson, A. B. Straughn, D. Dale, E. S. Umstot, N. Chiamori, and G. E. Abraham. Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies. Am. J. Obstet. Gynecol. 166:1163-8 (1992).
J. Y. Yang, A. Schwartz, and E. E. Henderson. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res. Hum. Retroviruses 9:747-54 (1993).
K. T. Khaw. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J. Endocrinol. 150:S149-153 (1996).
O. M. Wolkowitz, V. I. Reus, E. Roberts, F. Manfredi, T. Chan, W. J. Raum, S. Ormiston, R. Johnson, J. Canick, L. Brizendine, and H. Weingartner. Dehydroepiandrosterone (DHEA) treatment of depression. Biol.-Psychiatry 41:311-318 (1997).
P. R. Casson, S. A. Carson, and J. E. Buster. Replacement of dehydroepiandrosterone in the ederly: rationale and prospects for the future. Endocrinologist 8:187-194 (1998).
A. Kim, P. G. Green, G. Rao, and R. H. Guy. Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10:1315-1320 (1993).
P. G. Green, R. S. Hinz, A. Kim, F. C. Szoka, and R. H. Guy. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm. Res. 8:1121-1127 (1991).
L. Z. Benet and J. E. Goyan, Potentiometric determination of dissociation constants. J. Pharm. Sci. 56:665-680 (1967).
P. Santi, P. L. Catellani, P. Colombo, C. Ringard-Lefebvre, C. Barthélémy, and A. M. Guyot-Hermann. Partition and transport of verapamil and nicotine through artificial membranes. Int. J. Pharm. 68:43-49 (1991).
J. Hirvonen, J. H. Rytting, P. Paronen, and A. Urtti. Dodecyl N,N-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin. Pharm. Res. 8:933-937 (1991).
P. Colombo and P. Santi. Metodo ionoforetico per la somministrazione di farmaci e composizione farmaceutica solida per la sua realizzazione, Italian Patent Application, MI94A002047 (1994).
J. Boehnlein, A. Sakr, J. L. Lichtin, and R. L. Bronaugh. Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (Vitamin A) during percutaneous absorption. Pharm. Res. 11:1155-1159 (1994).
C. C. Cullander. What are the pathways of iontophoretic current flow through mammalian skin? Adv. Drug Del. Rev. 9:119-135 (1992).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laneri, S., Sacchi, A., di Frassello, E.A. et al. Ionized Prodrugs of Dehydroepiandrosterone for Transdermal lontophoretic Delivery. Pharm Res 16, 1818–1824 (1999). https://doi.org/10.1023/A:1018991023618
Issue Date:
DOI: https://doi.org/10.1023/A:1018991023618